Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis
- 1 July 2002
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 40 (1) , 178-183
- https://doi.org/10.1053/ajkd.2002.33927
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros StudyNephrology Dialysis Transplantation, 2001
- Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of DialysisJournal of the American Society of Nephrology, 2001
- Residual renal function and mortality risk in hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATIONTransplantation, 2001
- Cancer risk in patients on dialysis and after renal transplantationThe Lancet, 2000
- Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease populationKidney International, 1999
- Patterns of malignancies following renal transplantationTransplantation Proceedings, 1999
- INFECTIONS AFTER RENAL ALLOGRAFT FAILURE IN PATIENTS WITH OR WITHOUT LOW-DOSE MAINTENANCE IMMUNOSUPPRESSION1Transplantation, 1997
- Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patientsNephrology Dialysis Transplantation, 1996
- Markov Models in Medical Decision MakingMedical Decision Making, 1993